文献速递肝病

乳酸乳球菌乳脂亚种对西式饮食所致代谢变化的保护作用

Lactococcus lactis Subspecies cremoris Elicits Protection Against Metabolic Changes Induced by a Western-Style Diet.
PubMed 文献 · Gastroenterology · 2020-03-10

该研究在雌性C57BL/6小鼠中评估了口服乳酸乳球菌乳脂亚种ATCC 19257对西式饮食(40%脂肪、43%碳水化合物)诱导的代谢紊乱的影响。与对照菌相比,补充该菌16周(每周3次、每次1×10^9 CFU)的小鼠体重增加更少、肝脏脂肪变性和炎症更轻、血清胆固醇更低、葡萄糖耐量改善。提示该菌可能对西式饮食相关代谢和肝脏疾病有保护作用。

要点

  • 在西式饮食小鼠中,补充乳酸乳球菌乳脂亚种可减轻体重增加和肝脏脂肪变性。
  • 该菌可降低血清胆固醇水平并改善葡萄糖耐量。
  • 该菌口服安全,可能用于西式饮食相关代谢和肝脏疾病。

核心结论

  • 在雌性小鼠中,补充乳酸乳球菌乳脂亚种ATCC 19257可减轻西式饮食诱导的体重增加、肝脏脂肪变性和炎症,降低血清胆固醇,改善葡萄糖耐量。

研究设计与样本

  • 研究使用雌性C57BL/6小鼠,分别喂食含40%脂肪(主要为乳脂)和43%碳水化合物(主要为蔗糖)的西式饮食或热量匹配的对照饮食。
  • 饮食补充1×10^9 CFU的乳酸乳球菌乳脂亚种ATCC 19257或对照菌鼠李糖乳杆菌GG ATCC 53103,每周3次,持续16周。

主要发现

  • 与对照菌相比,补充乳酸乳球菌乳脂亚种的小鼠体重增加更少,肝脏脂肪变性和炎症更轻。
  • 补充该菌的小鼠平均血清胆固醇水平和体重指数低于对照菌组。
  • 补充该菌的小鼠葡萄糖耐量改善,肝脏脂质(包括氧化脂质)发生改变。

临床怎么用

  • 当前证据来自动物实验,提示乳酸乳球菌乳脂亚种可能作为益生菌用于西式饮食相关代谢和肝脏疾病,但尚未在人体中验证。

局限性

  • 研究仅纳入雌性小鼠,结果不能直接外推至人类或其他性别。
  • 样本量、具体统计值和效应量未在摘要中报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: A Western-style diet, which is high in fat and sugar, can cause significant dyslipidemia and nonalcoholic fatty liver disease; the diet has an especially strong effect in women, regardless of total calorie intake. Dietary supplementation with beneficial microbes might reduce the detrimental effects of a Western-style diet. We assessed the effects of Lactococcus lactis subspecies (subsp) cremoris on weight gain, liver fat, serum cholesterol, and insulin resistance in female mice on a high-fat, high-carbohydrate diet. METHODS: Female C57BL/6 mice were fed either a high-fat, high-carbohydrate (Western-style) diet that contained 40% fat (mostly milk fat) and 43% carbohydrate (mostly sucrose) or a calorie-matched-per-gram control diet. The diets of mice were supplemented with 1 × 109 colony-forming units of L lactis subsp cremoris ATCC 19257 or Lactobacillus rhamnosus GG ATCC 53103 (control bacteria) 3 times per week for 16 weeks. Body weights were measured, and fecal, blood, and liver tissues were collected and analyzed. Livers were analyzed for fat accumulation and inflammation, and blood samples were analyzed for cholesterol and glucose levels. Mice were housed within Comprehensive Lab Animal Monitoring System cages, and respiratory exchange ratio and activity were measured. Hepatic lipid profiles of L lactis subsp cremoris-supplemented mice were characterized by lipidomics mass spectrometry analysis. RESULTS: Mice fed L lactis subsp cremoris while on the Western-style diet gained less weight, developed less hepatic steatosis and inflammation, and had a lower mean serum level of cholesterol and body mass index than mice fed the control bacteria. Mice fed the L lactis subsp cremoris had increased glucose tolerance while on the Western-style diet compared to mice fed control bacteria and had alterations in hepatic lipids, including oxylipins. CONCLUSIONS: Dietary supplementation with L lactis subsp cremoris in female mice on a high-fat, high-carbohydrate (Western-style) diet caused them to gain less weight, develop less liver fat and inflammation, reduce serum cholesterol levels, and increase glucose tolerance compared with mice on the same diet fed control bacteria. L lactis subsp cremoris is safe for oral ingestion and might be developed for persons with metabolic and liver disorders caused by a Western-style diet.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Naudin CR, Maner-Smith K, Owens JA, et al. Lactococcus lactis Subspecies cremoris Elicits Protection Against Metabolic Changes Induced by a Western-Style Diet. Gastroenterology. 2020. PMID: 32169430. doi:10.1053/j.gastro.2020.03.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。